Conditioned medium obtained from in vitro differentiated adipocytes and resistin induce insulin resistance in human hepatocytes

FEBS Letters

Volumn 581, Issue 22, 2007, Pages 4303-4308

  Zhou, Lei ^b   Sell, Henrike ^a   Eckardt, Kristin ^a   Yang, Zaiqing ^b   Eckel, Jürgen ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Adipokines; Insulin resistance; Resistin; Type 2 diabetes

Indexed keywords

ADIPOCYTOKINE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; TROGLITAZONE;

ADIPOCYTE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INSULIN RESISTANCE; LIVER CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADIPOCYTES; ADIPONECTIN; CELL DIFFERENTIATION; CHROMANS; CULTURE MEDIA, CONDITIONED; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HEPATOCYTES; HUMANS; INSULIN RESISTANCE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RESISTIN; THIAZOLIDINEDIONES;

RODENTIA;

EID: 34548124842     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.07.076     Document Type: Article

References (39)

1. Mohamed-Ali V., Pinkney J.H., and Coppack S.W. Adipose tissue as an endocrine and paracrine organ. Int. J. Obes. Relat. Metab. Disord. 22 (1998) 1145-1158
2. Trayhurn P., and Beattie J.H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc. 60 (2001) 329-339
3. Holcomb I.N., Kabakoff R.C., Chan B., Baker T.W., Gurney A., Henzel W., Nelson C., Lowman H.B., Wright B.D., Skelton N.J., Frantz G.D., Tumas D.B., Peale Jr. F.V., Shelton D.L., and Hebert C.C. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. Embo J 19 (2000) 4046-4055
4. Kim K.H., Lee K., Moon Y.S., and Sul H.S. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J. Biol. Chem. 276 (2001) 11252-11256
5. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., and Lazar M.A. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
6. Patel L., Buckels A.C., Kinghorn I.J., Murdock P.R., Holbrook J.D., Plumpton C., Macphee C.H., and Smith S.A. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem. Biophys. Res. Commun. 300 (2003) 472-476
7. Curat C.A., Wegner V., Sengenes C., Miranville A., Tonus C., Busse R., and Bouloumie A. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49 (2006) 744-747
8. Taniguchi C.M., Ueki K., and Kahn R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J. Clin. Invest. 115 (2005) 718-727
9. Muse E.D., Obici S., Bhanot S., Monia B.P., McKay R.A., Rajala M.W., Scherer P.E., and Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 114 (2004) 232-239
10. Hauner H., Petruschke T., Russ M., Rohrig K., and Eckel J. Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 38 (1995) 764-771
11. Sell H., Dietze-Schroeder D., Kaiser U., and Eckel J. Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 147 (2006) 2458-2467
12. Dietze D., Ramrath S., Ritzeler O., Tennagels N., Hauner H., and Eckel J. Inhibitor kappaB kinase is involved in the paracrine crosstalk between human fat and muscle cells. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 985-992
13. Wichelhaus A., Russ M., Petersen S., and Eckel J. G protein expression and adenylate cyclase regulation in ventricular cardiomyocytes from STZ-diabetic rats. Am. J. Physiol. 267 (1994) H548-H555
14. Dietze D., Koenen M., Rohrig K., Horikoshi H., Hauner H., and Eckel J. Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 51 (2002) 2369-2376
15. Saltiel A.R., and Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799-806
16. Kusminski C.M., McTernan P.G., and Kumar S. Role of resistin in obesity, insulin resistance and Type II diabetes. Clin. Sci. (Lond.) 109 (2005) 243-256
17. Moon B., Kwan J.J., Duddy N., Sweeney G., and Begum N. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E106-E115
18. Pravenec M., Kazdova L., Landa V., Zidek V., Mlejnek P., Jansa P., Wang J., Qi N., and Kurtz T.W. Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J. Biol. Chem. 278 (2003) 45209-45215
19. Nakata M., Okada T., Ozawa K., and Yada T. Resistin induces insulin resistance in pancreatic islets to impair glucose-induced insulin release. Biochem. Biophys. Res. Commun. 353 (2007) 1046-1051
20. Rangwala S.M., Rich A.S., Rhoades B., Shapiro J.S., Obici S., Rossetti L., and Lazar M.A. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53 (2004) 1937-1941
21. Bokarewa M., Nagaev I., Dahlberg L., Smith U., and Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 174 (2005) 5789-5795
22. Silswal N., Singh A.K., Aruna B., Mukhopadhyay S., Ghosh S., and Ehtesham N.Z. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem. Biophys. Res. Commun. 334 (2005) 1092-1101
23. McTernan P.G., McTernan C.L., Chetty R., Jenner K., Fisher F.M., Lauer M.N., Crocker J., Barnett A.H., and Kumar S. Increased resistin gene and protein expression in human abdominal adipose tissue. J. Clin. Endocrinol. Metab. 87 (2002) 2407
24. McTernan P.G., Fisher F.M., Valsamakis G., Chetty R., Harte A., McTernan C.L., Clark P.M., Smith S.A., Barnett A.H., and Kumar S. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J. Clin. Endocrinol. Metab. 88 (2003) 6098-6106
25. Savage D.B., Sewter C.P., Klenk E.S., Segal D.G., Vidal-Puig A., Considine R.V., and O'Rahilly S. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50 (2001) 2199-2202
26. Combs T.P., Berg A.H., Obici S., Scherer P.E., and Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 108 (2001) 1875-1881
27. Rajala M.W., and Scherer P.E. Minireview: The adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144 (2003) 3765-3773
28. Sugimoto M., Takeda N., Nakashima K., Okumura S., Takami K., Yoshino K., Hattori J., Ishimori M., Takami R., Sasaki A., and Yasuda K. Effects of troglitazone on hepatic and peripheral insulin resistance induced by growth hormone excess in rats. Metabolism 47 (1998) 783-787
29. Aoki K., Saito T., Satoh S., Mukasa K., Kaneshiro M., Kawasaki S., Okamura A., and Sekihara H. Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone. Diabetes 48 (1999) 1579-1585
30. Ono M., Ikegami H., Fujisawa T., Nojima K., Kawabata Y., Nishino M., Taniguchi H., Itoi-Babaya M., Babaya N., Inoue K., and Ogihara T. Improvement of liver function parameters in patients with type 2 diabetes treated with thiazolidinediones. Metabolism 54 (2005) 529-532
31. Greenberg A.S., and Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am. J. Clin. Nutr. 83 (2006) 461S-465S
32. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., Coupaye M., Pelloux V., Hugol D., Bouillot J.L., Bouloumie A., Barbatelli G., Cinti S., Svensson P.A., Barsh G.S., Zucker J.D., Basdevant A., Langin D., and Clement K. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54 (2005) 2277-2286
33. Cancello R., Tordjman J., Poitou C., Guilhem G., Bouillot J.L., Hugol D., Coussieu C., Basdevant A., Hen A.B., Bedossa P., Guerre-Millo M., and Clement K. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55 (2006) 1554-1561
34. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25 (2004) 677-686
35. Gordon S., and Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5 (2005) 953-964
36. Lumeng C.N., Bodzin J.L., and Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117 (2007) 175-184
37. Wang Z., Lv J., Zhang R., Zhu Y., Zhu D., Sun Y., Zhu J., and Han X. Co-culture with fat cells induces cellular insulin resistance in primary hepatocytes. Biochem. Biophys. Res. Commun. 345 (2006) 976-983
38. Azuma K., Katsukawa F., Oguchi S., Murata M., Yamazaki H., Shimada A., and Saruta T. Correlation between serum resistin level and adiposity in obese individuals. Obes. Res. 11 (2003) 997-1001
39. Degawa-Yamauchi M., Bovenkerk J.E., Juliar B.E., Watson W., Kerr K., Jones R., Zhu Q., and Considine R.V. Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 88 (2003) 5452-5455